Pc. Mehaffey et al., ANTIGONOCOCCAL ACTIVITY OF 11 DRUGS USED FOR THERAPY OR PROPHYLAXIS OF MALARIA, Diagnostic microbiology and infectious disease, 23(1-2), 1995, pp. 11-13
Antibacterial agents are often used in malarial endemic areas for anti
malarial prophylaxis (such as doxycycline and clindamycin). Gonococcal
infections may coexist in the same geographic area, thus becoming sup
pressed by compounds directed toward malarial parasites. We tested 11
drugs with activity for Plasmodium species against 105 Neisseria gonor
rhoeae strains. Traditional or investigational antimalarials such as a
rteflene (Ro 42-1611), chloroquine, primaquine, pyrimethamine, quinacr
ine, and quinine were observed to be inactive. Fansidar (sulfadoxine-p
yrimethamine) and mefloquine possess marginal action in a minority of
gonococcus strains (<10%). Doxycycline [minimum inhibitory concentrati
on inhibiting 90% of tested strains (MIC(90)) 2 mu g/ml] and azithromy
cin (MIC(90), 0.5 mu g/ml) among the antibacterials were very active,
indicating a dual role as antimalarial and antigonococcal agents. Thus
, the gonorrhea and sexually transmitted disease epidemiologic data fr
om geographic regions where doxycycline or newer macrolides may be use
d for malarial prophylaxis or therapy could be significantly altered.